Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H17N3O3S2 |
| Molecular Weight | 327.422 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1)S(=O)(=O)NC2=NN=C(CC(C)C)S2
InChI
InChIKey=LZCBNYVJTNCPDR-UHFFFAOYSA-N
InChI=1S/C13H17N3O3S2/c1-9(2)8-12-14-15-13(20-12)16-21(17,18)11-6-4-10(19-3)5-7-11/h4-7,9H,8H2,1-3H3,(H,15,16)
| Molecular Formula | C13H17N3O3S2 |
| Molecular Weight | 327.422 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14400418
Diabetes patients were
started on four tablets of 250 mg (1 g) of stabinol (given
in a single dose in the morning).
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:40:18 GMT 2025
by
admin
on
Wed Apr 02 08:40:18 GMT 2025
|
| Record UNII |
887VHL8899
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29711
Created by
admin on Wed Apr 02 08:40:18 GMT 2025 , Edited by admin on Wed Apr 02 08:40:18 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000084236
Created by
admin on Wed Apr 02 08:40:18 GMT 2025 , Edited by admin on Wed Apr 02 08:40:18 GMT 2025
|
PRIMARY | |||
|
CHEMBL1481457
Created by
admin on Wed Apr 02 08:40:18 GMT 2025 , Edited by admin on Wed Apr 02 08:40:18 GMT 2025
|
PRIMARY | |||
|
1195
Created by
admin on Wed Apr 02 08:40:18 GMT 2025 , Edited by admin on Wed Apr 02 08:40:18 GMT 2025
|
PRIMARY | |||
|
34014
Created by
admin on Wed Apr 02 08:40:18 GMT 2025 , Edited by admin on Wed Apr 02 08:40:18 GMT 2025
|
PRIMARY | |||
|
3567-08-6
Created by
admin on Wed Apr 02 08:40:18 GMT 2025 , Edited by admin on Wed Apr 02 08:40:18 GMT 2025
|
PRIMARY | |||
|
Glysobuzole
Created by
admin on Wed Apr 02 08:40:18 GMT 2025 , Edited by admin on Wed Apr 02 08:40:18 GMT 2025
|
PRIMARY | |||
|
DTXSID0046276
Created by
admin on Wed Apr 02 08:40:18 GMT 2025 , Edited by admin on Wed Apr 02 08:40:18 GMT 2025
|
PRIMARY | |||
|
C65813
Created by
admin on Wed Apr 02 08:40:18 GMT 2025 , Edited by admin on Wed Apr 02 08:40:18 GMT 2025
|
PRIMARY | |||
|
234310
Created by
admin on Wed Apr 02 08:40:18 GMT 2025 , Edited by admin on Wed Apr 02 08:40:18 GMT 2025
|
PRIMARY | |||
|
SUB07958MIG
Created by
admin on Wed Apr 02 08:40:18 GMT 2025 , Edited by admin on Wed Apr 02 08:40:18 GMT 2025
|
PRIMARY | |||
|
887VHL8899
Created by
admin on Wed Apr 02 08:40:18 GMT 2025 , Edited by admin on Wed Apr 02 08:40:18 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |